Cancer Research UK logo.
SearchDonate
  • Search

A trial of GDC-0068 with abiraterone for prostate cancer that is no longer responding to hormone therapy

Overview

Cancer types:

Prostate cancer

Status:

Closed

Phase:

Phase 2

Details

This trial is looking at a drug called GDC-0068 alongside abiraterone for prostate cancer that has stopped responding to hormone therapy.

The trial is for men with prostate cancer that has got worse despite having docetaxel chemotherapy.

Recruitment start: 17 October 2013

Recruitment end: 13 October 2014

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Professor Johann De Bono

Supported by

Experimental Cancer Medicine Centre (ECMC)

Genentech Ltd

NIHR Clinical Research Network: Cancer

Last reviewed: 06 Nov 2014

CRUK internal database number: 9719

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Questions for your doctor

What to ask your doctor about clinical trials.

An icon of two speech bubbles, indicating a conversation.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.